Almirall SA (ALMRY)
14.28
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Almirall Shareholders Equity (Quarterly) : 1.737B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.737B |
| March 31, 2016 | 1.676B |
| December 31, 2015 | 1.589B |
| September 30, 2015 | 1.562B |
| June 30, 2015 | 1.549B |
| March 31, 2015 | 1.521B |
| December 31, 2014 | 1.621B |
| September 30, 2014 | 1.189B |
| June 30, 2014 | 1.242B |
| March 31, 2014 | 1.237B |
| December 31, 2013 | 1.224B |
| September 30, 2013 | 1.279B |
| June 30, 2013 | 1.222B |
| March 31, 2013 | 1.204B |
| December 31, 2012 | 1.218B |
| September 30, 2012 | 1.219B |
| June 30, 2012 | 1.121B |
| March 31, 2012 | 1.165B |
| December 31, 2011 | 1.110B |
| September 30, 2011 | 1.153B |
| June 30, 2011 | 1.219B |
| Date | Value |
|---|---|
| March 31, 2011 | 1.208B |
| December 31, 2010 | 1.099B |
| September 30, 2010 | 1.119B |
| June 30, 2010 | 963.53M |
| March 31, 2010 | 1.088B |
| December 31, 2009 | 1.077B |
| September 30, 2009 | 1.082B |
| June 30, 2009 | 984.78M |
| March 31, 2009 | 948.11M |
| December 31, 2008 | 907.69M |
| September 30, 2008 | 924.43M |
| June 30, 2008 | 959.50M |
| March 31, 2008 | 976.72M |
| December 31, 2007 | 838.71M |
| September 30, 2007 | |
| June 30, 2007 | 725.58M |
| March 31, 2007 | 516.46M |
| December 31, 2006 | 1.006B |
| June 30, 2006 | |
| March 31, 2006 | 1.142B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 776.47M |
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.685B |
| Total Liabilities (Quarterly) | 947.80M |